Scynexis Inc

Research Scynexis Inc (SCYX) on Bullrun: market cap USD 38.43M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSCYX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 38.43M
• Financial periodFY2025
• RevenueUSD 20.60M
• Revenue growth449.9%
• Net income-USD 8.61M

Valuation Snapshot

latest market cap is USD 38.43M.

About Scynexis Inc

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc.

Frequently asked questions

What is Scynexis Inc's market cap?

Scynexis Inc's market capitalization is USD 38.43M.

What does Scynexis Inc do?

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States.